Yimikang Tech.Group Co., Ltd.

SZSE:300249 Stok Raporu

Piyasa değeri: CN¥3.8b

Yimikang Tech.Group Bilanço Sağlığı

Finansal Sağlık kriter kontrolleri 4/6

Yimikang Tech.Group has a total shareholder equity of CN¥424.2M and total debt of CN¥352.9M, which brings its debt-to-equity ratio to 83.2%. Its total assets and total liabilities are CN¥1.6B and CN¥1.2B respectively.

Anahtar bilgiler

83.2%

Borç/özkaynak oranı

CN¥352.93m

Borç

Faiz karşılama oranın/a
NakitCN¥124.57m
EşitlikCN¥424.18m
Toplam yükümlülüklerCN¥1.19b
Toplam varlıklarCN¥1.62b

Son finansal sağlık güncellemeleri

Güncelleme yok

Recent updates

What Yimikang Tech.Group Co., Ltd.'s (SZSE:300249) 32% Share Price Gain Is Not Telling You

Sep 30
What Yimikang Tech.Group Co., Ltd.'s (SZSE:300249) 32% Share Price Gain Is Not Telling You

Some Confidence Is Lacking In Yimikang Tech.Group Co., Ltd. (SZSE:300249) As Shares Slide 28%

Apr 22
Some Confidence Is Lacking In Yimikang Tech.Group Co., Ltd. (SZSE:300249) As Shares Slide 28%

Getting In Cheap On Yimikang Tech.Group Co., Ltd. (SZSE:300249) Is Unlikely

Feb 28
Getting In Cheap On Yimikang Tech.Group Co., Ltd. (SZSE:300249) Is Unlikely

Finansal Durum Analizi

Kısa Vadeli Yükümlülükler: 300249's short term assets (CN¥1.1B) exceed its short term liabilities (CN¥1.1B).

Uzun Vadeli Yükümlülükler: 300249's short term assets (CN¥1.1B) exceed its long term liabilities (CN¥95.2M).


Borç-Özkaynak Tarihçesi ve Analizi

Borç Seviyesi: 300249's net debt to equity ratio (53.8%) is considered high.

Borcun Azaltılması: 300249's debt to equity ratio has increased from 80.9% to 83.2% over the past 5 years.


Bilanço


Nakit Pist Analizi

Geçmişte ortalama olarak zarar eden şirketler için, en az 1 yıllık nakit akışına sahip olup olmadıklarını değerlendiriyoruz.

İstikrarlı Nakit Pisti: Whilst unprofitable 300249 has sufficient cash runway for more than 3 years if it maintains its current positive free cash flow level.

Tahmini Nakit Akışı: 300249 is unprofitable but has sufficient cash runway for more than 3 years, due to free cash flow being positive and growing by 20.4% per year.


Sağlıklı şirketleri keşfedin